World News: 21:15 GMT Thursday 6th December 2018. [Eidos Therapeutics, Inc. via Globe Newswire via SPi World News]
SAN FRANCISCO Dec 06 2018 GLOBE NEWSWIRE -- Eidos Therapeutics Inc Eidos NasdaqEIDX a clinical stage biopharmaceutical company focused on addressing the large unmet need in transthyretin TTR amyloidosis (ATTR), today announced the appoint...
Globe Newswire: 21:15 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.